Venclaxta Tablet 10 mg contains Venetoclax, an oral targeted therapy used primarily in the treatment of certain hematologic cancers, including chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Venetoclax is a BCL-2 inhibitor, which works by inducing programmed cell death (apoptosis) in cancer cells that overexpress the BCL-2 protein, helping to reduce tumor burden and control disease progression.

Venclaxta provides a precise and targeted approach to cancer treatment, often used in combination with other therapies such as monoclonal antibodies or chemotherapeutic agents. It is indicated for patients with specific genetic markers and requires careful dosing to minimize side effects while maximizing efficacy.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Benefits

• Targeted Cancer Therapy: Specifically inhibits BCL-2, promoting apoptosis in cancer cells.

• Effective in Hematologic Malignancies: Used in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

• Oral Administration: Convenient daily dosing without the need for intravenous therapy.

• Combination Therapy Compatible: Can be safely combined with other cancer treatments under supervision.

• Precision Medicine Approach: Particularly effective in patients with 17p deletion or other genetic markers indicating high-risk disease.

Mechanism of Action

Venetoclax works by:

• Inhibiting BCL-2 Protein: Blocks the anti-apoptotic protein BCL-2, allowing cancer cells to undergo programmed cell death.

• Restoring Apoptosis: Targets malignant cells that are resistant to normal cell death signals, reducing cancer cell survival.

• Enhancing Chemotherapy Response: Often used with other agents to improve overall treatment efficacy.

Indications

Venclaxta Tablet 10 mg is indicated for:

• Chronic lymphocytic leukemia (CLL) with or without 17p deletion

• Small lymphocytic lymphoma (SLL)

• Use in combination therapy as determined by a hematologist/oncologist

• Suitable for patients who are not candidates for standard chemotherapy

Dosage and Administration

• Administer once daily, as prescribed by a physician.

• Start with a gradual dose ramp-up to reduce the risk of tumor lysis syndrome (TLS).

• Take with food and a full glass of water to improve absorption.

• Regular blood tests and monitoring for TLS, complete blood count, and kidney function are required.

Precautions

• Use under strict medical supervision with frequent monitoring.

• Adequate hydration is necessary to prevent tumor lysis syndrome.

• Avoid grapefruit and certain medications that interact with CYP3A enzymes.

• Pregnancy and breastfeeding should be avoided during treatment unless advised by a physician.

• Inform your doctor about all medications and supplements being taken to prevent interactions.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Common side effects may include:

• Diarrhea or nausea

• Fatigue

• Low white blood cell counts (neutropenia)

• Fever

Serious side effects may include:

• Tumor lysis syndrome

• Severe infections

• Low platelet counts or anemia

Immediate medical attention is required if symptoms like sudden weakness, unusual bruising, or severe nausea occur.

Storage

Store in a cool, dry place below 25°C. Protect from light and moisture. Keep out of reach of children.